Moneyview IPO review: valuation, risks, demand

Moneyview IPO dates and listing chatter

Moneyview IPO discussions online largely focus on the September 2026 schedule. Posts widely cite the issue opening on September 24, 2026 and closing on September 28, 2026. The allotment date being shared is September 29, 2026. Many posts also mention an expected listing date of October 1, 2026. Where investors are split is the listing venue detail. Some social posts say it will list on BSE and NSE. A few posts also reference NSE SME Emerge, which conflicts with the mainboard listing mentions. Because of these inconsistencies, commenters are relying on the most repeated dates while waiting for final exchange confirmation.

Issue size, structure, and what money is being raised

The issue size discussed most often is ₹1,091.68 crore. Social posts break this into a ₹750 crore fresh issue plus an offer for sale component. The OFS is described as up to 10,04,94,200 equity shares with a face value of ₹1 each. Several notes also describe the overall IPO as a book-built issue. A separate viral post claimed a different structure, including a ₹1,500 crore fresh issue and a larger OFS, but this conflicts with the ₹1,091.68 crore figure repeated across threads. Investors on Reddit have been flagging such discrepancies as a reason to double-check primary documents. The primary use of proceeds being discussed is to support loan disbursals and strengthen the NBFC subsidiary. Overall, the structure is being read as growth funding plus partial exits by existing holders.

Price band, lot size, and quota split

Moneyview IPO price band is being shared as ₹32 to ₹34 per share. Retail investors are discussing a minimum investment of ₹14,994 based on a lot size of 441 shares. The allocation split circulating online is 35% for retail, 50% for QIB, and 15% for HNI. The low absolute share price is being viewed as accessible, but posters also stress that affordability does not reduce business risk. Some users are comparing the band with reported valuation multiples and arguing about whether it leaves enough upside. Others are treating the IPO primarily as a listing-gains trade, contingent on demand and grey market signals. A repeated caution is to avoid over-weighting GMP over fundamentals. Another theme is that fintech underwriting quality matters more than the headline subscription numbers.

What Moneyview does and why scale is central

Moneyview is described as a digital financial services platform and marketplace. It connects users with banks, NBFCs, and insurers through its app. Multiple posts cite 48 financial partners as part of the platform model. User scale is a key talking point, with figures of 140.28 million users and 14.03 crore registered users appearing in different notes. The business is repeatedly framed as serving “Middle India” borrowers. One note specifies a household income band of ₹3-11 lakh annually for its core segment. The capital-light Lending Service Provider model is highlighted as a reason some brokerages like the story. The underwriting layer is also being emphasised, including claims of an AI and ML engine trained on more than 1,00,000 data variables.

Operating and financial snapshot shared in threads

The most cited headline numbers are from FY 2026. Posts claim income grew 43% to ₹3,404.27 crore in FY 2026. They also claim PAT rose only 1% to ₹242.71 crore, which drives the “growth but flat profit” debate. A separate brokerage note mentions revenue growth at a 58% CAGR over FY24 to FY26. The same note highlights EBITDA margin expansion from 23.2% to 33.5 over FY24 to FY26. Another widely shared operating metric is assets under management. Threads cite AUM of ₹22,520.17 crore as of June 30, 2026. Commenters interpret these metrics as strong top-line traction but mixed profit conversion. The result is a split between growth-focused buyers and risk-focused skeptics.

Valuation debate: P/E, P/B, and market-cap references

Valuation is a major reason the IPO is trending on finance forums. One popular review states a post-issue P/E of 8.61 times at ₹34. Another brokerage note from BP Equities pegs valuation at 21.7 times FY26 reported earnings at ₹34, which is materially higher than 8.61. The same BP note says this is at a discount to a stated peer average of 82.4 times P/E. On the balance sheet side, posts cite price-to-book around 2.62 times in one review. Other notes cite post-issue P/B of about 2.0 times at the upper band. Another widely circulated calculation puts the post-issue market cap near ₹5,985 crore, with about 1.9 times post-issue book value. Investors are treating the range of multiples as a sign that assumptions and definitions differ across sources. The practical takeaway in threads is to reconcile the valuation method before taking exposure.

What brokerages and reviewers are recommending

A key reason for strong engagement is that most broker reviews shared are broadly positive. BP Equities rates the issue “Subscribe” and focuses on the capital-light model and underwriting technology. Ventura Securities also recommends “Subscribe” and highlights the growth and margin trend discussed in its note. Samco Securities is cited as recommending “Subscribe” specifically for listing gains, with a suggestion to monitor the position after listing for long-term holding. SBI Securities is shared as recommending “Subscribe” for the long term, anchoring on post-issue P/B. Alongside these, a Chanakya-style review circulating on social media tags it as “Selective Apply.” That same review says listing gains depend on GMP and subscription staying healthy. A contrasting view circulating says long-term investors may give it a pass for now, citing risk-factor clarity as a reason to wait.

Risks highlighted most often: DLG, asset quality, and regulation

Risk discussion is unusually detailed in the Reddit threads for this IPO. One repeated risk is DLG exposure, with DLG outstanding cited at ₹1,061 crore. The same note frames that as 43.9% of net worth, which is repeatedly called out as material. Asset quality is another focus area, with gross Stage 3 loans said to have risen from 0.94% to 2.74% over FY24 to FY26. Several posters link this to a tougher unsecured credit cycle and higher impairment costs. Historically negative operating cash flows are also listed as a concern in shared notes. Dependence on financial partners is framed as both a scale advantage and a concentration risk. Regulatory changes are cited as a key uncertainty for unsecured loan growth. Finally, the flat FY26 profit growth relative to revenue is treated as a signal to stress-test the model under higher credit costs.

Subscription signals and what investors are watching next

Subscription data has been shared in fragments across posts. One tracker snapshot claims an overall subscription of 97.68 times, but it is presented without full category breakup. Another widely shared update says bids came in for 33,48,61,002 shares against 23,25,24,175 shares available. The same update says non-institutional investors led demand and subscribed 2.43 times. Investors are noting that these numbers may reflect different time stamps or reporting formats. The common approach in discussions is to watch the quality of subscription across QIB, HNI, and retail, rather than only the headline multiple. Many posters are also watching GMP, but treating it as a sentiment indicator rather than a valuation tool. With listing expected around October 1, 2026 in many posts, attention is shifting to whether early demand sustains. For longer-term holders, commenters are focused on how credit costs and Stage 3 trends evolve post-IPO.